249 related articles for article (PubMed ID: 20600803)
1. Enhanced toxicity and ROS generation by doxorubicin in primary cultures of cardiomyocytes from neonatal metallothionein-I/II null mice.
Fu Z; Guo J; Jing L; Li R; Zhang T; Peng S
Toxicol In Vitro; 2010 Sep; 24(6):1584-91. PubMed ID: 20600803
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein-I/II null cardiomyocytes are sensitive to Fusarium mycotoxin butenolide-induced cytotoxicity and oxidative DNA damage.
Yang HY; Wang YM; Peng SQ
Toxicon; 2010 Jun; 55(7):1291-6. PubMed ID: 20144643
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of doxorubicin toxicity in cultured neonatal mouse cardiomyocytes with elevated metallothionein levels.
Wang GW; Kang YJ
J Pharmacol Exp Ther; 1999 Mar; 288(3):938-44. PubMed ID: 10027829
[TBL] [Abstract][Full Text] [Related]
4. Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome c release and caspase-3 activation in cardiomyocytes.
Wang GW; Klein JB; Kang YJ
J Pharmacol Exp Ther; 2001 Aug; 298(2):461-8. PubMed ID: 11454906
[TBL] [Abstract][Full Text] [Related]
5. JAK2/STAT3 Pathway Mediates Protection of Metallothionein Against Doxorubicin-Induced Cytotoxicity in Mouse Cardiomyocytes.
Rong J; Li L; Jing L; Fang H; Peng S
Int J Toxicol; 2016 May; 35(3):317-26. PubMed ID: 26526549
[TBL] [Abstract][Full Text] [Related]
6. Metallothionein acts as a cytoprotectant against doxorubicin toxicity.
Kimura T; Fujita I; Itoh N; Muto N; Nakanishi T; Takahashi K; Azuma J; Tanaka K
J Pharmacol Exp Ther; 2000 Jan; 292(1):299-302. PubMed ID: 10604962
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of naringenin-7-O-glucoside against oxidative stress induced by doxorubicin in H9c2 cardiomyocytes.
Han XZ; Gao S; Cheng YN; Sun YZ; Liu W; Tang LL; Ren DM
Biosci Trends; 2012 Feb; 6(1):19-25. PubMed ID: 22426099
[TBL] [Abstract][Full Text] [Related]
8. Cell-permeable superoxide dismutase and glutathione peroxidase mimetics afford superior protection against doxorubicin-induced cardiotoxicity: the role of reactive oxygen and nitrogen intermediates.
Konorev EA; Kennedy MC; Kalyanaraman B
Arch Biochem Biophys; 1999 Aug; 368(2):421-8. PubMed ID: 10441396
[TBL] [Abstract][Full Text] [Related]
9. Metallothionein protects against doxorubicin-induced cardiomyopathy through inhibition of superoxide generation and related nitrosative impairment.
Shuai Y; Guo JB; Peng SQ; Zhang LS; Guo J; Han G; Dong YS
Toxicol Lett; 2007 Apr; 170(1):66-74. PubMed ID: 17382496
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart.
Sun X; Zhou Z; Kang YJ
Cancer Res; 2001 Apr; 61(8):3382-7. PubMed ID: 11309296
[TBL] [Abstract][Full Text] [Related]
11. Global gene expression profiles of MT knockout and wild-type mice in the condition of doxorubicin-induced cardiomyopathy.
Shuai Y; Guo J; Dong Y; Zhong W; Xiao P; Zhou T; Zhang L; Peng S
Toxicol Lett; 2011 Jan; 200(1-2):77-87. PubMed ID: 21040762
[TBL] [Abstract][Full Text] [Related]
12. Zinc-induced metallothionein overexpression prevents doxorubicin toxicity in cardiomyocytes by regulating the peroxiredoxins.
Jing L; Li L; Zhao J; Zhao J; Sun Z; Peng S
Xenobiotica; 2016 Aug; 46(8):715-25. PubMed ID: 26599915
[TBL] [Abstract][Full Text] [Related]
13. Basal metallothionein-I/II protects against NMDA-mediated oxidative injury in cortical neuron/astrocyte cultures.
Yu X; Guo J; Fang H; Peng S
Toxicology; 2011 Mar; 282(1-2):16-22. PubMed ID: 21215786
[TBL] [Abstract][Full Text] [Related]
14. Cytoprotective effect of anthocyanins against doxorubicin-induced toxicity in H9c2 cardiomyocytes in relation to their antioxidant activities.
Choi EH; Chang HJ; Cho JY; Chun HS
Food Chem Toxicol; 2007 Oct; 45(10):1873-81. PubMed ID: 17524543
[TBL] [Abstract][Full Text] [Related]
15. The influence of the time interval between monoHER and doxorubicin administration on the protection against doxorubicin-induced cardiotoxicity in mice.
Bruynzeel AM; Mul PP; Berkhof J; Bast A; Niessen HW; van der Vijgh WJ
Cancer Chemother Pharmacol; 2006 Nov; 58(5):699-702. PubMed ID: 16565833
[TBL] [Abstract][Full Text] [Related]
16. Metallothionein prevents doxorubicin cardiac toxicity by indirectly regulating the uncoupling proteins 2.
Jing L; Yang M; Li Y; Yu Y; Liang B; Cao L; Zhou X; Peng S; Sun Z
Food Chem Toxicol; 2017 Dec; 110():204-213. PubMed ID: 29061315
[TBL] [Abstract][Full Text] [Related]
17. Peroxiredoxins are involved in metallothionein protection from doxorubicin cardiotoxicity.
Jing L; Wu Y; Wu J; Zhao J; Zuo D; Peng S
Eur J Pharmacol; 2011 Jun; 659(2-3):224-32. PubMed ID: 21463615
[TBL] [Abstract][Full Text] [Related]
18. The protective effect of Ganoderma atrum polysaccharide against anoxia/reoxygenation injury in neonatal rat cardiomyocytes.
Li WJ; Nie SP; Yan Y; Zhu SB; Xie MY
Life Sci; 2009 Oct; 85(17-18):634-41. PubMed ID: 19744500
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of buthionine sulfoximine-enhanced doxorubicin toxicity in metallothionein overexpressing transgenic mouse heart.
Wu HY; Kang YJ
J Pharmacol Exp Ther; 1998 Nov; 287(2):515-20. PubMed ID: 9808675
[TBL] [Abstract][Full Text] [Related]
20. 4'-Epidoxorubicin to re-explore anthracycline degradation in cardiomyocytes.
Menna P; Salvatorelli E; Minotti G
Chem Res Toxicol; 2009 Jun; 22(6):978-83. PubMed ID: 19397277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]